Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+6.48%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$76.3B
AUM Growth
+$3.71B
(+5.1%)
Cap. Flow
-$8.94B
Cap. Flow
% of AUM
-11.71%
Top 10 Holdings %
Top 10 Hldgs %
21.64%
Holding
2,671
New
223
Increased
746
Reduced
756
Closed
309
Top Buys
| 1 |
Norfolk Southern
NSC
|
+$289M |
| 2 |
Union Pacific
UNP
|
+$247M |
| 3 |
UnitedHealth
UNH
|
+$246M |
| 4 |
CyberArk
CYBR
|
+$171M |
| 5 |
Chevron
CVX
|
+$161M |
Top Sells
| 1 |
Analog Devices
ADI
|
+$278M |
| 2 |
Meta Platforms (Facebook)
META
|
+$199M |
| 3 |
Aon
AON
|
+$188M |
| 4 |
PNC Financial Services
PNC
|
+$131M |
| 5 |
PayPal
PYPL
|
+$125M |
Sector Composition
| 1 | Technology | 18.85% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.89% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HIBB
501
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $5.65M | 0.01% |
95,778
+1,489
| +2% | +$87.8K |
|
502
Mettler-Toledo International
MTD
$25.8B
| $5.61M | 0.01% |
3,663
-240
| -6% | -$367K |
|
503
CRISPR Therapeutics
CRSP
$4.71B
| $5.6M | 0.01% |
123,789
+1,434
| +1% | +$64.8K |
|
504
Oracle
ORCL
$922B
| $5.59M | 0.01% |
60,154
+33,651
| +127% | +$3.13M |
|
505
Tyson Foods
TSN
$19.7B
| $5.57M | 0.01% |
93,899
+662
| +0.7% | +$39.3K |
|
506
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| – | – |
0
| – | -$5.41M |
|
507
Allison Transmission
ALSN
$7.41B
| $5.51M | 0.01% |
121,791
-20,740
| -15% | -$938K |
|
508
10x Genomics
TXG
$1.57B
| $5.5M | 0.01% |
98,614
-269
| -0.3% | -$15K |
|
509
Unum
UNM
$12.6B
| $5.47M | 0.01% |
138,283
+15,020
| +12% | +$594K |
|
510
Eletrobras Common Shares
EBR
$19.1B
| $5.45M | 0.01% |
821,882
-31,373
| -4% | -$208K |
|
511
Bank of America Series L
BAC.PRL
$3.93B
| $5.4M | 0.01% |
4,627
+108
| +2% | +$126K |
|
512
Zillow
ZG
$20B
| $5.4M | 0.01% |
123,487
+121,799
| +7,216% | +$5.32M |
|
513
DexCom
DXCM
$29.8B
| $5.4M | 0.01% |
46,446
-31,357
| -40% | -$3.64M |
|
514
Allegro MicroSystems
ALGM
$5.65B
| $5.38M | 0.01% |
112,174
-20,808
| -16% | -$999K |
|
515
BJs Wholesale Club
BJ
$12.8B
| $5.37M | 0.01% |
70,608
-177,387
| -72% | -$13.5M |
|
516
Telephone and Data Systems
TDS
$4.45B
| $5.35M | 0.01% |
509,078
+500,369
| +5,745% | +$5.26M |
|
517
N-able
NABL
$1.53B
| $5.35M | 0.01% |
404,987
-143,436
| -26% | -$1.89M |
|
518
RenaissanceRe
RNR
$11.2B
| $5.34M | 0.01% |
26,666
+18,278
| +218% | +$3.66M |
|
519
Idexx Laboratories
IDXX
$51B
| $5.24M | 0.01% |
10,469
+1,471
| +16% | +$736K |
|
520
Brixmor Property Group
BRX
$8.51B
| $5.22M | 0.01% |
242,614
-51,869
| -18% | -$1.12M |
|
521
Rayonier
RYN
$4.04B
| $5.2M | 0.01% |
164,160
+10,342
| +7% | +$327K |
|
522
Northrop Grumman
NOC
$83B
| $5.19M | 0.01% |
11,247
+2,392
| +27% | +$1.1M |
|
523
AptarGroup
ATR
$8.98B
| $5.14M | 0.01% |
43,502
+43,416
| +50,484% | +$5.13M |
|
|
NVRO
524
DELISTED
NEVRO CORP.
NVRO
| $5.13M | 0.01% |
142,038
+1,246
| +0.9% | +$45K |
|
525
IBM
IBM
$239B
| $5.11M | 0.01% |
38,985
+2,057
| +6% | +$270K |
|